Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Open
Phase 3
This trial is comparing chemotherapy with MK-2870 for non small cell lung cancer (NSCLC).
It is for people whose cancer has certain gene changes () in the lung cancer cells and:
the cancer has spread into nearby tissues and it isn't possible to treat it with surgery or radiotherapy or
the cancer has spread to another part of the body
Recruitment start: 3 July 2024
Recruitment end: 11 March 2030
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Adam Januszewski
Merck Sharp & Dohme Ltd
Last reviewed: 27 January 2025
CRUK internal database number: 19877
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
